Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Puma Biotechnology Inc (NASDAQ: PBYI) improved in the last week. PBYI’s current Value Trend Rating is B and the prior Rating was C. Details supporting this higher rating are included in our next report.
Recent Price Action
Puma Biotechnology Inc (NASDAQ: PBYI) stock closed at $4.66 on 3/18/24 after a large decline of -6.8%. Moreover, this decline was accompanied by exceptionally high trading volume at 207% of normal. The stock has declined -12.9% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
PBYI is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Puma Biotechnology has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Puma Biotechnology has a neutral Appreciation Score of 41 but a very high Power Rating of 86, leading to the Positive Value Trend Rating.
Be the first to comment